Parameters | No. of patients | Chi square | P | Multivariate analysis Odds ratio (95% CI) | P | |
---|---|---|---|---|---|---|
Head Body-tail | ||||||
Cases | 351 | |||||
Age (years) | ||||||
≤ 65 | 240 | 157 | 83 | 0.125 | ||
> 65 | 111 | 63 | 48 | |||
Gender | ||||||
Male | 210 | 131 | 79 | 0.911 | ||
Female | 141 | 89 | 52 | |||
Tumor size (cm) | ||||||
< 2 | 35 | 28 | 7 | 0.027 | ||
≥ 2 | 316 | 192 | 124 | |||
Tumor size (cm) | ||||||
< 3 | 108 | 84 | 24 | 0.000 | 2.133(1.180–3.856) | 0.012 |
≥ 3 | 243 | 136 | 107 | |||
Differentiation | ||||||
Well | 140 | 86 | 54 | 0.793 | ||
Moderate | 118 | 73 | 45 | |||
poor | 93 | 61 | 32 | |||
Lymph nodes metastasis | ||||||
N0 | 244 | 155 | 89 | 0.101 | ||
N1 | 91 | 59 | 32 | |||
N2 | 16 | 6 | 10 | |||
7th T stagea | ||||||
T1 + T2 | 242 | 159 | 83 | 0.114 | ||
T3 | 103 | 58 | 45 | |||
7th AJCC stageb | 0.360 | |||||
IA | 19 | 13 | 6 | |||
IB | 140 | 86 | 54 | |||
IIA | 76 | 45 | 31 | |||
IIB | 104 | 71 | 33 | |||
IV | 6 | 2 | 4 | |||
8th T stage | ||||||
T1 + T2 | 202 | 140 | 62 | 0.003 | 1.344(0.805–2.243) | 0.258 |
T3 + T4 | 149 | 80 | 69 | |||
8th AJCC stage | 0.000 | |||||
IA | 24 | 18 | 6 | |||
IB | 119 | 84 | 35 | |||
IIA | 93 | 42 | 51 | |||
IIB | 86 | 66 | 20 | |||
III | 23 | 8 | 15 | |||
IV | 6 | 2 | 4 | |||
8th AJCC stage | ||||||
I + II | 321 | 209 | 112 | 0.002 | 2.520(1.121–5.665) | 0.025 |
III + IV | 30 | 11 | 19 | |||
Perineural invasion | ||||||
Absent | 278 | 180 | 98 | 0.118 | ||
Present | 73 | 40 | 33 | |||
Vascular permeation | ||||||
Absent | 266 | 172 | 94 | 0.174 | ||
Present | 85 | 48 | 37 | |||
Pre-therapeutic CA19–9 level | ||||||
Mean ± SD | / | 389.6 ± 255.7 | 324.2 ± 283.3 | 0.429 | ||
PLM | ||||||
Absent | 227 | 156 | 71 | 0.002 | 1.854(1.160–2.963) | 0.010 |
Present | 124 | 64 | 60 |